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Catamenial pneumothorax may be suspected in ovulating women with spontaneous
pneumothorax even in the absence of symptoms of pelvic endometriosis. During VATS,
inspection of the diaphragmatic surface is paramount. Plication of the involved area alone can
be successful. In complicated cases, hormonal suppression therapy is a helpful adjunct.
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Laparoscopic reoperation for failed fundoplication is feasible and can achieve resolution of
symptoms for a significant percentage of patients.
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tumor from colorectal carcinoma: Utility as a prognostic factor
Masaya Tamura, MD, Makoto Oda, MD, Yoshio Tsunezuka, MD, Isao Matsumoto, MD,
Kazuyuki Kawakami, MD, and Go Watanabe, MD, Kanazawa, Japan
The number of pulmonary metastatic tumors and the presence of positive VEGF expression in
metastatic tumors are the factors that determine the long-term survival of patients with
resectable pulmonary metastasis from colorectal carcinoma. Patients with multiple and positive
VEGF expression in the metastatic tumor will not receive benefit from metastasectomy.
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choice for multidrug-resistant tuberculosis
Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Naoya Katsuragi, MD, Makoto Kurai, MD, and
Nobumasa Takahashi, MD, Tokyo, Japan
Between 2000 and 2002, 30 patients with multidrug-resistant tuberculosis underwent 33
pulmonary resections in combination with intensive multidrug regimens. Of the 29 survivors,
27 were free from disease, with a median follow-up of 24 months. Pulmonary resection
combined with chemotherapy achieved high cure rates for multidrug-resistant tuberculosis.
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